Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

404 ARTÍCULOS , VIENDO DEL 76 AL 90

Leveraging hallmark Alzheimer's molecular targets using phytoconstituents: Current perspective and emerging trends

Dhage PA, Sharbidre AA, Dakua SP, Balakrishnan S.

Biomed Pharmacother. 2021 Jul;139:111634. doi: 10.1016/j.biopha.2021.111634. Epub 2021 May 6.

Safety and Tolerability of GRF6019 Infusions in Severe Alzheimer's Disease: A Phase II Double-Blind Placebo-Controlled Trial

Hannestad J, Duclos T, Chao W, Koborsi K, Klutzaritz V, Beck B, Patel AK, Scott J, Thein SG, Cummings JL, Kay G, Braithwaite S, Nikolich K.

J Alzheimers Dis. 2021;81(4):1649-1662. doi: 10.3233/JAD-210011.

Individualized Prediction of Early Alzheimer's Disease Based on Magnetic Resonance Imaging Radiomics, Clinical, and Laboratory Examinations: A 60-Month Follow-Up Study

Tang L, Wu X, Liu H, Wu F, Song R, Zhang W, Guo D, Feng J, Li C.

J Magn Reson Imaging. 2021 Nov;54(5):1647-1657. doi: 10.1002/jmri.27689. Epub 2021 May 13.

Does the application of acetylcholinesterase inhibitors in the treatment of Alzheimer's disease lead to depression?

Mitić M, Lazarević-Pašti T.

Expert Opin Drug Metab Toxicol. 2021 Jul;17(7):841-856. doi: 10.1080/17425255.2021.1931681. Epub 2021 Jun 10.

MADRID+90 study on factors associated with longevity: Study design and preliminary data

Fernández-Blázquez MA, Del Ser T, Frades-Payo B, Ávila-Villanueva M, Valentí-Soler M, Benítez-Robredo MT, Bermejo-Aguña A, Pedrero-Pérez EJ, Quilis-Sancho J, Pastor AB, Fernández-Garrido C, Morales-Alonso S, Diaz-Olalla JM, Santos NC, Maestú F, Gómez-Ramírez J.

PLoS One. 2021 May 17;16(5):e0251796. doi: 10.1371/journal.pone.0251796. eCollection 2021.

New IDEAS Amyloid Imaging 2021 Study: Running in Place with Ineffective Anti-Amyloid Treatments for Alzheimer's Disease Patients

Barrio JR, Whitehouse P, Alavi A, Høilund-Carlsen PF.

J Alzheimers Dis. 2021;82(2):461-462. doi: 10.3233/JAD-210383.

Benefits in Alzheimer's Disease of Sensory and Multisensory Stimulation

Yang H, Luo Y, Hu Q, Tian X, Wen H.

J Alzheimers Dis. 2021;82(2):463-484. doi: 10.3233/JAD-201554.

Life Course Adiposity and Alzheimer's Disease: A Mendelian Randomization Study

Li X, Tian Y, Yang YX, Ma YH, Shen XN, Chen SD, Dong Q, Tan L, Yu JT.

J Alzheimers Dis. 2021;82(2):503-512. doi: 10.3233/JAD-210345.

The need to show minimum clinically important differences in Alzheimer's disease trials

Liu KY, Schneider LS, Howard R.

Lancet Psychiatry. 2021 Nov;8(11):1013-1016. doi: 10.1016/S2215-0366(21)00197-8. Epub 2021 Jun 1.

Proteopathic lesions in the brain of a super-aged chimpanzee (Pan troglodytes)

Iwaide S, Yanai T, Murakami T.

J Med Primatol. 2021 Aug;50(4):222-224. doi: 10.1111/jmp.12530. Epub 2021 Jun 7.

Diagnosis of Early Alzheimer's Disease: Clinical Practice in 2021

Porsteinsson AP, Isaacson RS, Knox S, Sabbagh MN, Rubino I.

J Prev Alzheimers Dis. 2021;8(3):371-386. doi: 10.14283/jpad.2021.23.

Neurodegenerative Diseases: A Multidisciplinary Approach

Marcos-Rabal P, González-Fuentes J, Castro-Vázquez L, Lozano MV, Rodríguez-Robledo V, Santander-Ortega MJ, Selva-Clemente J, Villaseca-González N, Del Mar Arroyo-Jiménez M.

Curr Pharm Des. 2021 Oct 5;27(30):3305-3336. doi: 10.2174/1381612827666210608152745.

Older Adults with Alzheimer's Disease: The Need to Improve Systems of Care

Hung WW.

Clin Ther. 2021 Jun;43(6):920-921. doi: 10.1016/j.clinthera.2021.05.007. Epub 2021 Jun 6.

Partial volume correction analysis for (11)C-UCB-J PET studies of Alzheimer's disease

Lu Y, Toyonaga T, Naganawa M, Gallezot JD, Chen MK, Mecca AP, van Dyck CH, Carson RE.

Neuroimage. 2021 Sep;238:118248. doi: 10.1016/j.neuroimage.2021.118248. Epub 2021 Jun 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias